Extracorporeal Membrane Oxygenation Machine Market By Type , By Components By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Type

Veno-arterial
Veno-venous
Others

By Components

Pumps
Oxygenator
Controllers
Others

By Application

Adult
Pediatric
Neonates

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Medtronic Plc
Sorin Group
Terumo Corporation
MAQUET Holding
Nipro Medical Corporation
Microport Scientific Corporation
Medos Medizintechnik AG
GETINGE AB
Livanova Plc
Fresnius Medical Care

Product Code: A284556

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Veno-arterial
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Veno-venous
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Others
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Components
5.2. Pumps
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Oxygenator
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Controllers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Others
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country

CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
6.2. Adult
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Pediatric
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Neonates
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Components
- 7.2.4. Market Size and Forecast, By Application
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.2.6.1. Market Size and Forecast, By Type
  - 7.2.6.2. Market Size and Forecast, By Components
  - 7.2.6.3. Market Size and Forecast, By Application
- 7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.2.7.1. Market Size and Forecast, By Type
  - 7.2.7.2. Market Size and Forecast, By Components
  - 7.2.7.3. Market Size and Forecast, By Application
- 7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.2.8.1. Market Size and Forecast, By Type
  - 7.2.8.2. Market Size and Forecast, By Components
  - 7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Components
- 7.3.4. Market Size and Forecast, By Application
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.6.1. Market Size and Forecast, By Type
  - 7.3.6.2. Market Size and Forecast, By Components
  - 7.3.6.3. Market Size and Forecast, By Application
- 7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.7.1. Market Size and Forecast, By Type
  - 7.3.7.2. Market Size and Forecast, By Components
  - 7.3.7.3. Market Size and Forecast, By Application
- 7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.8.1. Market Size and Forecast, By Type
  - 7.3.8.2. Market Size and Forecast, By Components
  - 7.3.8.3. Market Size and Forecast, By Application
- 7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.9.1. Market Size and Forecast, By Type
  - 7.3.9.2. Market Size and Forecast, By Components
  - 7.3.9.3. Market Size and Forecast, By Application
- 7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.10.1. Market Size and Forecast, By Type
  - 7.3.10.2. Market Size and Forecast, By Components
  - 7.3.10.3. Market Size and Forecast, By Application
- 7.3.11. Rest of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.3.11.1. Market Size and Forecast, By Type
  - 7.3.11.2. Market Size and Forecast, By Components
  - 7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Components
- 7.4.4. Market Size and Forecast, By Application
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.6.1. Market Size and Forecast, By Type
  - 7.4.6.2. Market Size and Forecast, By Components
  - 7.4.6.3. Market Size and Forecast, By Application
- 7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.7.1. Market Size and Forecast, By Type
  - 7.4.7.2. Market Size and Forecast, By Components
  - 7.4.7.3. Market Size and Forecast, By Application
- 7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.8.1. Market Size and Forecast, By Type
  - 7.4.8.2. Market Size and Forecast, By Components
  - 7.4.8.3. Market Size and Forecast, By Application
- 7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.9.1. Market Size and Forecast, By Type
  - 7.4.9.2. Market Size and Forecast, By Components
  - 7.4.9.3. Market Size and Forecast, By Application
- 7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.10.1. Market Size and Forecast, By Type
  - 7.4.10.2. Market Size and Forecast, By Components
  - 7.4.10.3. Market Size and Forecast, By Application
- 7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.4.11.1. Market Size and Forecast, By Type
  - 7.4.11.2. Market Size and Forecast, By Components
  - 7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Components
- 7.5.4. Market Size and Forecast, By Application
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.5.6.1. Market Size and Forecast, By Type
  - 7.5.6.2. Market Size and Forecast, By Components
  - 7.5.6.3. Market Size and Forecast, By Application
- 7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.5.7.1. Market Size and Forecast, By Type
  - 7.5.7.2. Market Size and Forecast, By Components
  - 7.5.7.3. Market Size and Forecast, By Application
- 7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.5.8.1. Market Size and Forecast, By Type
  - 7.5.8.2. Market Size and Forecast, By Components
  - 7.5.8.3. Market Size and Forecast, By Application
- 7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
  - 7.5.9.1. Market Size and Forecast, By Type
  - 7.5.9.2. Market Size and Forecast, By Components
  - 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Medtronic Plc
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Sorin Group
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Terumo Corporation
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. MAQUET Holding
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Nipro Medical Corporation
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Microport Scientific Corporation
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. Medos Medizintechnik AG
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. GETINGE AB
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Livanova Plc
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Fresnius Medical Care
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments